A Study of SYHA1807 in Subjects With Extensive-Stage Small Cell Lung Cancer

NCT04404543 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

71

Enrollment

INDUSTRY

Sponsor class

Conditions

Extensive-Stage Small Cell Lung Cancer

Interventions

DRUG: SYHA1807
DRUG: SYHA1807

Sponsor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.